Sep 5 |
Eli Lilly signs research deal with AI-focused Genetic Leap
|
Sep 5 |
Qiagen and Lilly team up for Alzheimer’s genotype test
|
Sep 5 |
Eli Lilly Just Made Zepbound Even More Appealing. Here's What Smart Investors Need to Know.
|
Sep 5 |
Lilly builds case for weekly insulin shot
|
Sep 5 |
Eli Lilly marks late-stage trial win for once weekly insulin
|
Sep 5 |
In a first-of-its-kind fixed dose study, once weekly insulin efsitora alfa leads to A1C reduction similar to daily insulin
|
Sep 5 |
Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year
|
Sep 5 |
Lilly and EVA Pharma to expand baricitinib access in Africa
|
Sep 4 |
QIAGEN, Lilly to develop Alzheimer's risk detection test
|
Sep 4 |
UK regulators find no link between certain GLP-1 drugs, suicidal thoughts
|